- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Exercise therapy as a supplemental treatment strategy in early multiple sclerosis
2021.05.26 |
| Date | Fri 11 Jun |
| Time | 14:00 — 16:00 |
| Location | Online |
On Friday 11 June at 14:00, Morten Riemenschneider defends his PhD dissertation entitled "Exercise therapy as a supplemental treatment strategy in early multiple sclerosis – the Early Multiple Sclerosis Exercise Study (EMSES)".
The relapsing remitting type of multiple sclerosis (MS) is characterised by acute neurological relapses and accelerated brain atrophy. Medical disease-modifying treatments show superior efficacy when initiated early in the disease course. However, patients do still experience disease activity and physical and cognitive disabilities accumulate over time. Supplemental treatment strategies are therefore warranted. Exercise therapy is one of the most promising non-pharmacological approaches, showing beneficial effects on physical function and MS-related symptoms. The present PhD study however highlight an overlooked “window of opportunity” for exercise therapy early in the disease course of MS. Considering the indications of disease-modifying and neuroprotective effects of exercise therapy, early MS exercise studies are warranted. The present PhD study therefore aimed to investigate the efficacy of supervised aerobic exercise on measures of disease-modification, neuroprotection, and physical and cognitive function early in the disease course of MS.
The summary is written by the PhD student.
The defence is public and takes place online. Please read the attached press release for more information.
PhD student Morten Riemenschneider
Mail: mori@ph.au.dk
Phone: (+45) 22855185